On International Clinical Trials Days, one group of UQ researchers are working very hard.
Based at the Translational Research Institute, UQDI Dermatology Research Centre Director, Professor H. Peter Soyer said the team used trials to determine why some moles turned in to melanoma.
“Being able to carry out clinical trials are essential for us to test the effectiveness of our research so that our patients are able to gain access to new imaging modalities sooner.” Professor Soyer said.
“Doing clinical trials also allows us to know for sure if our new interventions are better than what has been done before.”
The Centre recently received a boost in NHMRC funding for a clinical trial supporting the use of whole body imaging for the early detection of melanoma.
One of the trials involves a world-first targeted screening program to assess clinical outcomes, health service outcomes and consumer behaviour outcomes of high risk participants using an innovative targeted screening program incorporating 3D total body photography.
“We hope that through the support for our clinical trials, we can reduce the time it takes to make this innovative new screening widely available.” Professor Soyer stated.
"We see patients on a daily basis who have been affected by melanoma.” Clinical Researcher, Dr Jenna Rayner said.
"Their highly valued participation in our research is pivotal to improving melanoma diagnosis and outcomes for future generations"
Clinical trials contribute to the advancement of scientific knowledge.
For more information about participating in a clinical trials in Australia:
https://www.australianclinicaltrials.gov.au/
https://www.dermcoll.edu.au/for-community/research-clinical-guidelines/